Key performance indicators | Total | Male | Female | |||
Relative frequency | % (95% CI) | Relative frequency | % (95% CI) | Relative frequency | % (95% CI) | |
DVT prophylaxis | 4255/16 114 | 26.4 (25.7 to 27.1) | 2547/9941 | 25.6 (24.8 to 26.5) | 1708/6173 | 27.7 (26.6 to 28.8) |
Dysphagia screen | 18 893/26 026 | 72.6 (72.1 to 73.1) | 11 852/16 325 | 72.6 (71.9 to 73.3) | 7040/9700 | 72.6 (71.7 to 73.5) |
Rehabilitation | 18 952/26 026 | 72.8 (72.3 to 73.4) | 11 864/16 325 | 72.7 (72.0 to 73.4) | 7087/9700 | 73.1 (72.2 to 73.9) |
BP lowering for HTN | 18 821/22 256 | 84.6 (84.1 to 85.0) | 11721/13 892 | 84.4 (83.8 to 85.0) | 7099/8363 | 84.9 (84.1 to 85.7) |
Glucose-lowering for hyperglycaemic | 2328/3362 | 69.2 (67.7 to 70.8) | 1378/2005 | 68.7 (66.7 to 70.8) | 950/1357 | 70.0 (67.6 to 72.5) |
Smoking cessation | 4482/4745 | 94.5 (93.8 to 95.1) | 4375/4615 | 94.8 (94.2 to 95.4) | 107/130 | 82.3 (75.8 to 88.9) |
Summary performance measures | ||||||
Composite score | 0.69±0.27 | 0.69±0.27 | 0.68±0.28 | |||
All-or-none measure | 7561/26 026 | 29.1 (28.5 to 29.6) | 4741/16 325 | 29.0 (28.3 to 29.7) | 2819/9700 | 29.1 (28.2 to 30.0) |
BP, blood pressure; DVR, deep vein thrombosis; HTN, hypertension.